Summary
Four analogues of parathyroid hormone were synthesized, based on a sequence previously shown to yield an in vitro inhibitor of PTH action. Binding properties of the analogues to presumed parathyroid hormone receptors were evaluated. Each of these analogues contains a structural alteration of the amino terminus of the compound [Nle-8,Nle-18,Tyr-34]bPTH-(3-34)amide. Each of the analogues—[desamino-Ser-3, Nle-8, Nle-18, Tyr-34]bPTH-(3-34)amide, [acetyl-Glu-4,Nle-8,Nle-18,Tyr-34]bPTH-(3-34)amide, [d-Ser-3,Nle-8,Nle-18,Tyr-34]bPTH-(3-34)amide, and [pyroGlu-4,Nle-8,Nle-18,Tyr-34]bPTH-(3-34)amide—contains modifications selected to diminish or eliminate the weak PTH-like agonist properties detected in the parent compound in vivo. To permit valid comparison of receptor-binding properties, all the analogues were derived from a common solid-phase synthesis. When assayed in the renal adenylate cyclase assay, each of the compounds inhibited completely PTH-stimulated adenylate cyclase activity and was devoid of PTH-like agonist activity. To compare the binding affinity of the analogues for parathyroid hormone binding sites, the peptides were evaluated in a parathyroid hormone renal radioreceptor assay. Each peptide demonstrated a binding affinity comparable with one another and only slightly weaker than that of the unmodified inhibitory analogue, [Nle-8,Nle-18,Tyr-34]bPTH-(3-34)amide. These studies demonstrate that it is possible to alter the amino terminus of parathyroid hormone analogues without causing a dramatic decline in affinity for the parathyroid hormone receptor. Preservation of high receptor-binding affinity in these analogues indicates that synthesis of one or several of these peptides on a scale sufficiently large to permit in vivo evaluation of both agonist and antagonist properties is warranted.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Rosenblatt, M., Callahan, E.N., Mahaffey, J.E., Pont, A., Potts, J.T., Jr.: Parathyroid hormone inhibitors: design, synthesis, and biologic evaluation of hormone analogues, J. Biol. Chem.252:5847–5851, 1977
Mahaffey, J.E., Rosenblatt, M., Shepard, G.L., Potts, J.T., Jr.: Parathyroid hormone inhibitors: determination of minimum sequence requirements, J. Biol. Chem.254:6496–6498, 1979
Segre, G.V., Tully, G.L., Rosenblatt, M., Laugharn, J.A., Reit, B., Potts, J.T., Jr.: Evaluation of an in vitro parathyroid hormone antagonist in intact dogs, Abstracts, Annual Meeting, American Society for Bone and Mineral Research, June, 1979, Calcif. Tissue Int.28:171, 1979
Goltzman, D., Peytremann, A., Callahan, E., Tregear, G.W., Potts, J.T., Jr.: Analysis of the requirements for parathyroid hormone action in renal membranes with the use of inhibiting analogues, J. Biol. Chem.250:3199–3203, 1975
Potts, J.T., Jr., Tregear, G.W., Keutmann, H.T., Niall, H.D., Sauer, R., Deftos, L.J., Dawson, B.F., Hogan, M.L., Aurbach, G.D.: Synthesis of a biologically active N-terminal tetratriacontapeptide of parathyroid hormone, Proc. Natl. Acad. Sci. U.S.A.68:63–67, 1971
Tregear, G.W., van Rietschoten, J., Greene, E., Keutmann, H.T., Niall, H.D., Parsons, J.A., Potts, J.T., Jr.: Principles and recent applications in the solid-phase synthesis of peptide hormones. In S. Taylor (ed.): Endocrinology 1973, pp. 1–15. Heinemann Medical Books Ltd., London, 1974
Parsons, J.A., Rafferty, B., Gray, D., Reit, B., Zanelli, J.M., Keutmann, H.T., Tregear, G.W., Callahan, E.N., Potts, J.T., Jr.: Pharmacology of parathyroid hormone and some of its fragments and analogues. In R.V. Talmage, M. Owen, J.A. Parsons (eds.): Calcium-Regulating Hormones: Proceedings of the Fifth Parathyroid Conference, pp. 34–39. Excerpta Medica, Amsterdam, 1975
Tregear, G.W., van Rietschoten, J., Greene, E., Keutmann, H.T., Niall, H.D., Reit, B., Parsons, J.A., Potts, J.T., Jr.: Bovine parathyroid hormone: minimum chain length of synthetic peptide required for biological activity, Endocrinology93:1349–1353, 1973
Tregear, G.W., Potts, J.T., Jr.: Synthetic analogues of residues 1–34 of human parathyroid hormone: influence of residue number 1 on biological potency in vitro, Endocrine Res. Commun.2:561–570, 1975
Rosenblatt, M., Keutmann, H.T., Tregear, G.W., Potts, J.T., Jr.: Synthesis of a fragment of human parathyroid hormone, hPTH-(44-68). J. Med. Chem.20:1452–1456, 1977
Rosenblatt, M., Segre, G.V., Potts, J.T., Jr.: Synthesis of a fragment of parathyroid hormone, bPTH-(28-48): an inhibitor of hormone cleavage in vivo, Biochemistry16:2811–2816, 1977
Erickson, B.W., Merrifield, R.B.: Solid-phase peptide synthesis. In H. Neurath, R.H. Hill (eds.): The Proteins, Vol. 2, Ed. 3, pp. 255–527, Academic Press, New York, 1976
Merrifield, R.B.: Peptide synthesis on a solid polymer, Fed. Proc.21:412, 1962
Merrifield, R.B.: Solid-phase synthesis. I. The synthesis of a tetrapeptide, J. Am. Chem. Soc.85:2149–2159, 1963
Merrifield, R.B.: Solid-phase peptide synthesis, Adv. Enzymol.32:221–296, 1969
Tregear, G.W., van Rietschoten, J., Sauer, R., Niall, H.D., Keutmann, H.T., Potts, J.T., Jr.: Synthesis, purification, and chemical characterization of the amino-terminal 1–34 fragment of bovine parathyroid hormone synthesized by the solid-phase procedure, Biochemistry16:2817–2823, 1977
Rosenblatt, M., Goltzman, D., Keutmann, H.T., Tregear, G.W., Potts, J.T., Jr.: Chemical and biological properties of synthetic sulfur-free analogues of parathyroid hormone, J. Biol. Chem.251:159–164, 1976
Bennett, H.P.J., Browne, C.A., Goltzman, D., Solomon, S.: In E. Gross, J. Meienhofer (eds.): Peptides: Chemistry and Biology (Proceedings of the Sixth American Peptide Symposium), pp. 121–124, Pierce Chemical Co., Rockford, 1979
Marcus, R., Aurbach, G.D.: Bioassay of parathyroid hormone in vitro with a stable preparation of adenyl cyclase from rat kidney, Endocrinology85:801–810, 1969
Marcus, R., Aurbach, G.D.: Adenyl cyclase from renal cortex, Biochim. Biophys. Acta242:410–421, 1971
Segre, G.V., Rosenblatt, M., Reiner, B.L., Mahaffey, J.E., Potts, J.T., Jr.: Characterization of parathyroid hormone receptors in canine renal cortical plasma membranes using a radioiodinated sulfur-free hormone analogue: correlation of binding with adenylate cyclase activity, J. Biol. Chem.254:6980–6986, 1979
Rosenblatt, M., Segre, G.V., Tyler, G.A., Shepard, G.L., Nussbaum, S.R., Potts, J.T., Jr.: Identification of a receptor-binding region in parathyroid hormone, Endocrinology107:545–550, 1980
Goldring, S.R., Mahaffey, J.E., Rosenblatt, M., Dayer, J.-M., Potts, J.T., Jr., Krane, S.M.: Parathyroid hormone inhibitors: comparison of biological activity in bone- and skinderived tissue, J. Clin. Endocrinol. Metab.48:655–659, 1979
Ferland, L., Labrie, F., Savary, M., Beaulieu, M., Coy, D.H., Coy, E.J., Schally, A.V.: Inhibitory activity of analogues of luteinizing hormone-releasing hormone, Clin. Endocrinol. [Suppl.]5:279s-289s, 1976
Vilchez-Martinez, J.A., Schally, A.V., Coy, D.H., Coy, E.J., Miller, C.M., III, Arimura, A.: An in vivo assay for anti-LH-RH and anti-FSH-RH activity of inhibitory analogues of LH-RH, Endocrinology96:1130–1134, 1975
Poulsen, K., Burton, J., Haber, E.: Competitive inhibitors of renin, Biochemistry12:3877–3882, 1973
Burton, J., Poulsen, K., Haber, E.: Competitive inhibitors of renin: inhibitors effective at physiological pH, Biochemistry14:3892–3898, 1975
Rudinger, J.: The design of peptide hormone analogues. In E.J. Ariens (ed.): Drug Design, Vol. II, pp. 319–419. Academic Press, New York, 1971
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rosenblatt, M., Potts, J.T. Analogues of an in vitro parathyroid hormone inhibitor: Modifications at the amino terminus. Calcif Tissue Int 33, 153–157 (1981). https://doi.org/10.1007/BF02409428
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02409428